Home > Hopetavir
Share
Hopetavir
Sofosbuvir 400 mg

Patients who are Initiating Therapy for HCV Infection or who Experienced Relapse after Prior Peginterferon alfa + Ribavirin Therapy

HCV monoinfected Treatment Duration
Patients with genotype 1 or 4 CHC Sofosbuvir + Peginterferon alfa + Ribavirin 12 Weeks
Patients with genotype 2 CHC Sofosbuvir + Ribavirin 12 Weeks
Patients with genotype 3 CHC Sofosbuvir + Ribavirin 24 Weeks

Recommendations for Patients in Whom Previous PEG/RBV Treatment Has Failed

HCV monoinfected & HCV / HIV-1 co-infected Treatment Duration
Patients with genotype 1 or 4 CHC Sofosbuvir + Peginterferon alfa + Ribavirin 12 Weeks
Patients with genotype 2 CHC Sofosbuvir + Ribavirin 12 Weeks
Patients with genotype 3 CHC Sofosbuvir + Ribavirin 24 Weeks